Camila Cabral Portugal obtained her BSc. degree in Biology in 2006, her master in Neuroimmunology in 2008 and her PhD, also in Neuroimmunology in 2012 at the Federal Fluminense University, in Brazil. During her PhD, Camila C. Portugal worked at the Biology Institute, at the Federal Fluminense University in Brazil and at the Centre of Ophthalmology and Vision Sciences, IBILI, at the University of Coimbra, in Portugal, in a split-site doctoral program from CAPES/FCT in a project entitled Vitamin C transport modulation in the Central Nervous System. Her PhD thesis received an Honorable Mention from the national Brazilian funding agency Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). Afterwards, Camila C. Portugal started working as a postdoctoral research fellow at the Institute for Molecular and Cell Biology (IBMC), Portugal. She published 29 articles in peer-reviewed journals (Times cited: 403; H index: 13 - Web of Science april/2020). Her last work in Science Signaling was very well accepted by the scientific community receiving highlights on two prestigious journals: one in Science by Dr. Annalisa VanHook and another in Nature Immunology by Dr. Laurie A. Dempsey. Camila published 6 book chapters, co-supervised 2 PhD thesis(es), supervised 1 MSc dissertation(s) and co-supervised 3. She also supervised 2 BSc final works and co-supervised 2. She has received 18 awards and/or honors. Now, Camila C. Portugal is a Junior researcher at Instituto de Investigação e Inovação em Saúde, i3S. She works in the area(s) of Medical and Health Sciences (Basic Medicine) with emphasis on Neurosciences. She develops a scientific project entitled "Regulation of microglia inflammatory profile by high affinity ascorbate transporter and its implication for Alzheimer´s Disease".